Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
Saved in:
Main Authors: | Chia-Jui Su, MD (Author), Han-Chi Tseng, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023) -
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023) -
Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021) -
Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
by: Madeeha Mian, MD, et al.
Published: (2020) -
Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)